However, it remains unclear whether specific irAE types drive this effect and how corticosteroid treatment of irAEs influences survival.<h4>Materials and methods</h4>A seven-year retrospective cohort study of 301 patients with advanced cutaneous melanoma treated with single-agent PD-1 inhibition at Sahlgrenska University Hospital. This evidence concerns the gene PDCD1 and cutaneous melanoma.